相似文献
1
A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12682-7. doi: 10.1073/pnas.0404875101. Epub 2004 Aug 16.
2
Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
Oncogene. 2005 May 19;24(22):3619-31. doi: 10.1038/sj.onc.1208433.
3
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7. doi: 10.1073/pnas.96.10.5522.
4
Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Oncogene. 2001 Jan 4;20(1):133-40. doi: 10.1038/sj.onc.1204052.
5
Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.
Biochem Biophys Res Commun. 2003 Sep 19;309(2):408-13. doi: 10.1016/j.bbrc.2003.08.019.
6
A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway.
Mol Cell Biol. 2003 Jun;23(11):3936-50. doi: 10.1128/MCB.23.11.3936-3950.2003.
7
Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes.
J Biol Chem. 2004 Apr 23;279(17):16927-38. doi: 10.1074/jbc.M309045200. Epub 2004 Feb 5.
8
Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation.
Biochem Pharmacol. 2002 Nov 1;64(9):1325-36. doi: 10.1016/s0006-2952(02)01345-x.
9
Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
J Biol Chem. 2002 Jul 5;277(27):24258-64. doi: 10.1074/jbc.M110602200. Epub 2002 May 1.
10
gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Genes Dev. 2000 Jun 1;14(11):1319-31.
引用本文的文献
1
The role of SH3RF2 in lung squamous cell carcinoma and M2 polarization: insights into LZTS2 ubiquitination.
Biol Direct. 2025 Jul 17;20(1):87. doi: 10.1186/s13062-025-00677-0.
2
REPS2 attenuates cancer stemness through inhibiting Wnt signaling by autophagy mediated degradation of β-catenin.
Oncogene. 2025 Jun 13. doi: 10.1038/s41388-025-03469-y.
3
A Model of Butyrate Activity and Resistance in CRC.
J Cell Mol Med. 2025 Jun;29(11):e70656. doi: 10.1111/jcmm.70656.
4
Safely Targeting Cancer, the Wound That Never Heals, Utilizing CBP/Beta-Catenin Antagonists.
Cancers (Basel). 2025 Apr 29;17(9):1503. doi: 10.3390/cancers17091503.
5
Oncogenic β-catenin stimulation of cofilin 1-mediated macropinocytosis is druggable for cancer.
Theranostics. 2025 Mar 17;15(9):4176-4187. doi: 10.7150/thno.104283. eCollection 2025.
6
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances.
Signal Transduct Target Ther. 2025 Apr 4;10(1):106. doi: 10.1038/s41392-025-02142-w.
7
Functional role for Taz during hindbrain ventricle morphogenesis.
PLoS One. 2025 Mar 13;20(3):e0313262. doi: 10.1371/journal.pone.0313262. eCollection 2025.
8
Dysregulation of the p300/CBP histone acetyltransferases in human cancer.
Epigenomics. 2025 Feb;17(3):193-208. doi: 10.1080/17501911.2024.2447807. Epub 2024 Dec 30.
9
Cellular Crosstalk Promotes Hepatic Progenitor Cell Proliferation and Stellate Cell Activation in 3D Co-culture.
Cell Mol Gastroenterol Hepatol. 2025;19(5):101472. doi: 10.1016/j.jcmgh.2025.101472. Epub 2025 Jan 30.
10
Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances.
Pharmaceuticals (Basel). 2024 Dec 20;17(12):1724. doi: 10.3390/ph17121724.
本文引用的文献
1
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex.
Cancer Cell. 2004 Jan;5(1):91-102. doi: 10.1016/s1535-6108(03)00334-9.
2
Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5.
EMBO J. 2003 Oct 1;22(19):5186-96. doi: 10.1093/emboj/cdg473.
3
Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding.
Methods. 2003 Sep;31(1):67-75. doi: 10.1016/s1046-2023(03)00089-6.
4
Survivin and molecular pathogenesis of colorectal cancer.
Lancet. 2003 Jul 19;362(9379):205-9. doi: 10.1016/S0140-6736(03)13910-4.
5
Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.
Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):391-400.
6
Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond.
Med Sci Monit. 2003 Apr;9(4):PI25-9.
7
Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors.
Mol Cancer Ther. 2002 Dec;1(14):1355-9.
8
Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis.
Br Med Bull. 2002;64:27-43. doi: 10.1093/bmb/64.1.27.
9
Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal.
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14789-94. doi: 10.1073/pnas.232568499. Epub 2002 Oct 23.
10
A novel stereo-selective sulfonylurea, 1-[1-(4-aminobenzoyl)-2,3-dihydro-1H-indol-6-sulfonyl]-4-phenyl-imidazolidin-2-one, has antitumor efficacy in in vitro and in vivo tumor models.
Biochem Pharmacol. 2002 Aug 1;64(3):473-80. doi: 10.1016/s0006-2952(02)01105-x.
Zotero 插件